|Day Low/High||0.04 / 0.04|
|52 Wk Low/High||0.01 / 0.21|
Temporary relocation reflects full commitment to complete capital restructuring
Covering Treatment of Diabetes with MANF
Data show in-animal increases in free-release dopamine and dopamine turnover
Once Issued, patent extends coverage for Eltoprazine in Europe into 2029 CEO to present at RedChip's Global Online Growth Conference on December 7, 2017
Dr. Scribner to Focus on Accelerated Regulatory Pathway for ESS
- Presentation and Live Webcast on October 9, 2015 at 11:25 a.m. PDT -
Company Simultaneously Repurchases All Outstanding Series G Convertible Preferred Stock
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.